Abogen Biosciences
Signal active
Investment Firm
Overview
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Highlights
Founded
2019
Industry
Biotechnology
Employees
501-1000
Investment
1
Lead Investment
0
Exits
undefined
Stages
Seed
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Abogen Biosciences, established in 2019 and headquartered in Asia., specializes in Seed investments across Biotechnology, Medical, Financial Services, Venture Capital, Finance. Their recent investments include Immupeutics Medicine, Lotus Lake Ventures, Alwin Capital, Purple Bull Startups. The highest investment round they participated in was $741.8M. Among their most notable exits are Immupeutics Medicine and Lotus Lake Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Abogen Biosciences has made 1 investments. Their most recent investment was on Sep 29, 2021, when Immupeutics Medicine raised $15.5M.
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Sep 29, 2021 | Immupeutics Medicine | Biotechnology | 15.5M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
38
Funds
0
Funding Rounds
1
Abogen Biosciences has raised 1 rounds. Their latest funding was raised on Sep 29, 2021 from a Seed Round - Immupeutics Medicine round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Sep 29, 2021 | Seed Round - Immupeutics Medicine | - | 15.5M | - |
Investors
45
Abogen Biosciences is funded by 45 investor(s). 5Y Capital and MiraeAsset Financial Group Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
IMO Ventures | No | Series C - Abogen Biosciences | 300.0M |
MiraeAsset Financial Group | No | Series C - Abogen Biosciences | 300.0M |
5Y Capital | Yes | Series C - Abogen Biosciences | 300.0M |
| - | Yes | Series C - Abogen Biosciences | 300.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.